{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:40:21Z","timestamp":1742316021602,"version":"3.40.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.xphs.2025.01.022","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:46:25Z","timestamp":1737996385000},"page":"103687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Observation of \u0190-Al13-Keggin-oligonucleotide complexes in analytical sample solutions"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0764-5397","authenticated-orcid":false,"given":"Jonathan C.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao V.","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1672-4529","authenticated-orcid":false,"given":"Carolyn L.","family":"Mazzitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.01.022_bib0001","unstructured":"N Fomiversen (VITRAVENE TM) in 1998, Pegaptanib (MACUGEN TM) in 2004 Mipomersen (KYNAMRO TM) in 2013, Nusinersen (SPINRAZA TM) and Eteplirsen (EXONDYS 51 TM) in 2016, Patisiran (ONPATTRO TM) and Inotersen (TEGSEDI TM) in 2018, Volanesorsen (WAYLIVRA TM), Givosiran (GIVLAARI TM) and Golodirsen (VYONDYS 53 TM) in 2019, Lumasiran (OXLUMO TM) and Inclisiran (LEQVIO TM), and Viltolarsen (VILTEPSO TM) in 2020, Casimersen (AMONDYS 45 TM) in 2021, Vuttrisiran (AMVUTTRA TM) in 2022, Tofersen (QALSODY TM), 2023, Nedosiran (RIVFLOZA TM), 2023, Eplontersen (WAINUA TM) in 2023."},{"issue":"6","key":"10.1016\/j.xphs.2025.01.022_bib0002","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/nar\/gkad067","article-title":"Chemistry, structure and function of approved oligonucleotide therapeutics","volume":"51","author":"Egli","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.xphs.2025.01.022_bib0003","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic antisense oligonucleotides are coming of age","volume":"70","author":"Bennett","year":"2019","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.xphs.2025.01.022_bib0004","series-title":"Antisense Drug Technology: Principles, Strategies, and Applications","first-page":"3","article-title":"Mechanisms of antisense drug action, an Introduction","author":"Crooke","year":"2007"},{"issue":"3","key":"10.1016\/j.xphs.2025.01.022_bib0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/nat.2021.0056","article-title":"Assay, purity, and impurity profile of phosphorothioate oligonucleotide therapeutics by ion pair\u2013HPLC\u2013MS","volume":"32","author":"Rentel","year":"2022","journal-title":"Nucleic Acids Therapeut"},{"issue":"1","key":"10.1016\/j.xphs.2025.01.022_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/cr040095d","article-title":"Large aqueous aluminum hydroxide molecules","volume":"106","author":"Casey","year":"2006","journal-title":"Chem Rev"},{"key":"10.1016\/j.xphs.2025.01.022_bib0007","series-title":"Antisense Drug Technology: Principles, Strategies and Applications","first-page":"401","article-title":"Manufacturing and analytical processes for 2\u2032-O-(2-methoxyethyl)-modified oligonucleotides","author":"Capaldi","year":"2008"},{"issue":"8","key":"10.1016\/j.xphs.2025.01.022_bib0008","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0965-9773(99)00412-2","article-title":"Novel synthesis of Al13-cluster based alumina materials","volume":"11","author":"Wang","year":"1999","journal-title":"NanoStruct Mater"},{"issue":"1","key":"10.1016\/j.xphs.2025.01.022_bib0009","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/07328319908045596","article-title":"Stability of phosphorothioate oligonucleotides in aqueous ammonia in presence of stainless steel","volume":"18","author":"Turney","year":"1999","journal-title":"Nucleosides Nucleotides"},{"key":"10.1016\/j.xphs.2025.01.022_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0021-9673(92)85456-4","article-title":"Separation of synthetic phosphorothioate oligodeoxynucleotides from their oxygenated (phosphodiester) defect species by strong-anion-exchange high-performance liquid chromatography","volume":"599","author":"Bergot","year":"1992","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.xphs.2025.01.022_bib0011","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2138\/rmg.2001.44.05","article-title":"Aqueous aluminum polynuclear complexes and nanoclusters: a review","volume":"44","author":"Casey","year":"2001","journal-title":"Rev Mineral Geochem"},{"key":"10.1016\/j.xphs.2025.01.022_bib0012","series-title":"Antiperspirants and Deoderants","first-page":"83","article-title":"Chemistry of aluminum chlorohydrate and activated aluminum chlorohydrates","author":"Fitzgerald","year":"1999"},{"key":"10.1016\/j.xphs.2025.01.022_bib0013","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3891\/acta.chem.scand.14-0771","article-title":"On the crystal structures of some basic aluminum salts","volume":"14","author":"Johansson","year":"1960","journal-title":"Acta Chem Scand"},{"issue":"97","key":"10.1016\/j.xphs.2025.01.022_bib0014","doi-asserted-by":"crossref","first-page":"11352","DOI":"10.1039\/c3cc44844d","article-title":"Controlled step-wise isomerization of the Keggin-type Al(13) and determination of the \u03b3-Al(13) structure","volume":"49","author":"Smart","year":"2013","journal-title":"Chem Commun"},{"key":"10.1016\/j.xphs.2025.01.022_bib0015","series-title":"Pharmaceutical Stress Testing: Predicting Drug Degradation","first-page":"391","article-title":"Stress testing of oligonucleotides","author":"Capaldi","year":"2005"},{"issue":"6","key":"10.1016\/j.xphs.2025.01.022_bib0016","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/ja00709a055","article-title":"Kinetics and mechanism of the acid-catalyzed hydrolysis of some purine nucleosides","volume":"92","author":"Zoltewicz","year":"1970","journal-title":"J Am Chem Soc"},{"issue":"3","key":"10.1016\/j.xphs.2025.01.022_bib0017","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1039\/C6CC08555E","article-title":"Polyoxometalates as artificial nucleases: hydrolytic cleavage of DNA promoted by a highly negatively charged ZrIV-substituted Keggin polyanion","volume":"53","author":"Luong","year":"2017","journal-title":"Chem Commun"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492500036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235492500036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T16:12:24Z","timestamp":1742314344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235492500036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S002235492500036X"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.01.022","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Observation of \u0190-Al13-Keggin-oligonucleotide complexes in analytical sample solutions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103687"}}